Bing Cao

机构：Ningbo Medical Center Lihuili Hospital · ORCID：0000-0002-0477-6872

发表论文 69 篇 · 总被引 821 次 · h-index 16

代表论文

• P-coumaric acid ameliorates Aβ25–35-induced brain damage in mice by modulating gut microbiota and serum metabolites (2023 · Biomedicine & Pharmacotherapy · 被引 27)
• Lipidomic analyses reveal the dysregulation of oxidized fatty acids (OxFAs) and acyl-carnitines (CARs) in major depressive disorder: a case-control study (2025 · BMC Psychiatry · 被引 10)
• Two polyphenols isolated from Corallodiscus flabellata B. L. Burtt ameliorate amyloid β-protein induced Alzheimer's disease neuronal injury by improving mitochondrial homeostasis (2022 · Behavioural Brain Research · 被引 10)
• Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics (2024 · BMC Medical Genomics · 被引 6)
• Futoquinol improves Aβ25–35‐induced memory impairment in mice by inhibiting the activation of p38MAPK through the glycolysis pathway and regulating the composition of the gut microbiota (2024 · Phytotherapy Research · 被引 6)
• Silibinin suppresses glioblastoma cell growth, invasion, stemness, and glutamine metabolism by YY1/SLC1A5 pathway (2024 · Translational Neuroscience · 被引 6)